Thrombin inhibition with dipeptidyl argininals

Thromb Res. 1988 May 15;50(4):461-7. doi: 10.1016/0049-3848(88)90195-8.

Abstract

Human alpha- and gamma-thrombins (with high and essentially no fibrinogen clotting activities, respectively) were inhibited in chromogenic substrate assays by the dipeptidyl argininals: antipain less than leupeptin less than H-D-Phe-Pro-argininal approximately Boc-D-Phe-Pro-argininal. In clotting assays with alpha-thrombin, I50 values were slightly higher than Ki values from chromogenic substrate assays, except for a somewhat lower I50 for antipain. Our data cautions the use of argininal proteinase inhibitors in the assessment of thrombin functions, and the high potency of H-D-Phe-Pro-argininal and its derivative suggest pharmaceutical applications.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antipain / pharmacology*
  • Blood Coagulation / drug effects
  • Kinetics
  • Leupeptins / pharmacology*
  • Oligopeptides / pharmacology*
  • Thrombin / antagonists & inhibitors*

Substances

  • Leupeptins
  • Oligopeptides
  • Antipain
  • H-D-Phe-Pro-arginal
  • tert-butyloxycarbonyl-phenylalanyl-prolyl-arginal
  • Thrombin
  • leupeptin